Clinical Trial Update: A Study to Assess the Safety and Efficacy of Prograf and MR4 in Liver Transplant Recipients [Phase 3]

View source ↗

Summary

Phase 3 trial assessing the safety and efficacy of Prograf (tacrolimus) with MR4 in liver transplant recipients has completed. The study was sponsored by Astell…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Transplantation

Drugs mentioned

• MR4
• Prograf (Tacrolimus)

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Liver Transplantation | Phase 3 | Status: COMPLETED